A5049926362- Peripheral Artery Disease Management
- Diabetic Foot Ulcer Assessment and Management
- Cardiac, Anesthesia and Surgical Outcomes
- Vascular Procedures and Complications
- Aortic aneurysm repair treatments
- Organ Transplantation Techniques and Outcomes
- Cerebrovascular and Carotid Artery Diseases
- Diagnosis and Treatment of Venous Diseases
- Reconstructive Surgery and Microvascular Techniques
- Liver Disease and Transplantation
- Venous Thromboembolism Diagnosis and Management
- Orthopedic Infections and Treatments
- Cardiovascular Health and Disease Prevention
- Pancreatic function and diabetes
- Wound Healing and Treatments
- Renal and Vascular Pathologies
- Acute Ischemic Stroke Management
- Renal Transplantation Outcomes and Treatments
- Diabetes and associated disorders
- Surgical site infection prevention
- Central Venous Catheters and Hemodialysis
- Infectious Aortic and Vascular Conditions
- Viral-associated cancers and disorders
- Diabetes Management and Research
- Streptococcal Infections and Treatments
Baylor College of Medicine
2016-2025
Michael E. DeBakey VA Medical Center
2015-2024
SUNY Downstate Health Sciences University
2022
Baylor School
2022
Creative Commons
2019
Association of Chartered Certified Accountants
2017
Brigham and Women's Hospital
2010-2016
Society for Cardiovascular Angiography and Interventions
2016
O'Neal Steel (United States)
2015
Vanderbilt University Medical Center
2008
Epstein-Barr virus (EBV) is a common viral infection in pediatric liver transplant patients and can lead to development of post-transplant lymphoproliferative disorder (PTLD). Differing studies have used immunosuppression reduction, antiviral medications or i.v. CMV-immunogloublin for EBV prevention treatment. The purpose this study was determine whether implementation protocol frequent monitoring load-driven reduction could decrease the incidence PTLD our patient population. All data were...
<h3>Importance</h3> Potentially preventable adverse events remain a formidable cause of patient harm and health care expenditure despite advances in systems-based risk-reduction strategies. <h3>Objective</h3> To analyze describe the incidence human performance deficiencies (HPDs) during provision surgical to identify opportunities enhance safety. <h3>Design, Setting, Participants</h3> This quality improvement study used new taxonomy inform development implementation an HPD classifier tool...
Severe portopulmonary hypertension (POPH) is an absolute contraindication to orthotopic liver transplantation (OLT). Vasodilators have been used, but the safety of subsequent and reversibility pulmonary after are uncertain. This study examined feasibility post-transplant effects following medical control POPH. Eight consecutive patients (three females five males, ages 39-51) with POPH as their only were treated continuous intravenous epoprostenol. Liver was considered if mean artery pressure...
Extended criteria donor (ECD) liver allografts are often allocated to less severely ill transplant (LT) candidates who at a relatively lower risk of pretransplant mortality, but it is not clear that the use ECD will decrease center waitlist mortality (WLM). Individual patient data from UNOS OPTN database (2002-2005) were aggregated obtain center-specific data. Deceased with any following characteristics defined as ECDs: described by New York State Department Health Workgroup; or 12+ h cold...
Biliary atresia is the most common indication for orthotopic liver transplantation (OLT) in pediatric population. The outcomes of biliary atresia, however, have not been formally examined on a national scale. objective this study was to identify pretransplant variables that predict patient survival after primary atresia. A cohort 1,976 patients undergoing between 1/1988 12/2003 enrolled from United Network Organ Sharing database excluding with history multiorgan transplant or previous...
Background. Orthotopic liver transplantation (OLT) is an effective treatment for fulminant hepatic failure (FHF), but postOLT mortality higher patients with FHF than other indications OLT. In the current study, a large cohort of who underwent OLT was evaluated to develop and validate system useful estimating patient survival. Methods. The 1,457 in United States between 1988 2003 were enrolled through UNOS database. This group divided into modeling (n=972) crossvalidation (n=486). With...
The pediatric end-stage liver disease (PELD) model accurately estimates 90-day waitlist mortality for transplant candidates, but it has been unclear if PELD can identify patients who will derive survival benefit from undergoing transplantation (LT), correlates with posttransplant survival, or whom LT would be futile. Pediatric underwent between 2001 and 2004 were enrolled through the United Network Organ Sharing Procurement Transplant database. Survival was measured in terms of life-years...
We sought to identify factors associated with treatment failure and leg amputations among those patients who presented foot osteomyelitis. Characteristics, treatments, outcomes for all treated probable or definite osteomyelitis (per consensus definition) between January 2011 March 2015 were reviewed. Multivariate Cox regression models used risk (unanticipated resection of additional bone amputation) amputation alone. A total 184 episodes met inclusion criteria. Treatment occurred in 53...
In the BEST-CLI trial (Best Endovascular Versus Best Surgical Therapy for Patients With Chronic Limb-Threatening Ischemia), a prespecified secondary objective was to assess effects of revascularization strategy on health-related quality life (HRQoL).